Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis

Abstract Chronic kidney disease is characterized by prolonged decline in renal function, excessive accumulation of ECM, and progressive tissue fibrosis. Transglutaminase (TG) is a crosslinking enzyme that catalyzes the formation of covalent bonds between glutamine and lysine residues, and is involve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hideki Tatsukawa, Risa Otsu, Yuji Tani, Ryosuke Wakita, Kiyotaka Hitomi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/66086460911a4f87a48181ed1f80a081
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:66086460911a4f87a48181ed1f80a081
record_format dspace
spelling oai:doaj.org-article:66086460911a4f87a48181ed1f80a0812021-12-02T16:08:03ZIsozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis10.1038/s41598-018-25674-42045-2322https://doaj.org/article/66086460911a4f87a48181ed1f80a0812018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25674-4https://doaj.org/toc/2045-2322Abstract Chronic kidney disease is characterized by prolonged decline in renal function, excessive accumulation of ECM, and progressive tissue fibrosis. Transglutaminase (TG) is a crosslinking enzyme that catalyzes the formation of covalent bonds between glutamine and lysine residues, and is involved in the induction of renal fibrosis via the stabilization of ECM and the activation of TGF-β1. Despite the accumulating evidences indicating that TG2 is a key enzyme in fibrosis, genetic knockout of TG2 reduced by only 50% the elevated protein crosslinking and fibrous protein in renal fibrosis model, whereas treatment with TG inhibitor almost completely reduced these levels. Here, we also clarified the distributions of TG isozymes and their in situ activities and identified the isozyme-specific crosslinked substrates for both TG1 and TG2 in fibrotic kidney. We found that TG1 activity was markedly enhanced in renal tubular epithelium and interstitial areas, whereas TG2 activity increased only in the extracellular space. In total, 47 and 67 possible candidates were identified as TG1 and TG2 substrates, respectively, only in fibrotic kidney. Among them, several possible substrates related to renal disease and fibrosis were identified. These findings provide novel insights into the mechanisms of renal fibrosis through the targeting of isozyme-specific TG substrates.Hideki TatsukawaRisa OtsuYuji TaniRyosuke WakitaKiyotaka HitomiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-18 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hideki Tatsukawa
Risa Otsu
Yuji Tani
Ryosuke Wakita
Kiyotaka Hitomi
Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
description Abstract Chronic kidney disease is characterized by prolonged decline in renal function, excessive accumulation of ECM, and progressive tissue fibrosis. Transglutaminase (TG) is a crosslinking enzyme that catalyzes the formation of covalent bonds between glutamine and lysine residues, and is involved in the induction of renal fibrosis via the stabilization of ECM and the activation of TGF-β1. Despite the accumulating evidences indicating that TG2 is a key enzyme in fibrosis, genetic knockout of TG2 reduced by only 50% the elevated protein crosslinking and fibrous protein in renal fibrosis model, whereas treatment with TG inhibitor almost completely reduced these levels. Here, we also clarified the distributions of TG isozymes and their in situ activities and identified the isozyme-specific crosslinked substrates for both TG1 and TG2 in fibrotic kidney. We found that TG1 activity was markedly enhanced in renal tubular epithelium and interstitial areas, whereas TG2 activity increased only in the extracellular space. In total, 47 and 67 possible candidates were identified as TG1 and TG2 substrates, respectively, only in fibrotic kidney. Among them, several possible substrates related to renal disease and fibrosis were identified. These findings provide novel insights into the mechanisms of renal fibrosis through the targeting of isozyme-specific TG substrates.
format article
author Hideki Tatsukawa
Risa Otsu
Yuji Tani
Ryosuke Wakita
Kiyotaka Hitomi
author_facet Hideki Tatsukawa
Risa Otsu
Yuji Tani
Ryosuke Wakita
Kiyotaka Hitomi
author_sort Hideki Tatsukawa
title Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
title_short Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
title_full Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
title_fullStr Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
title_full_unstemmed Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
title_sort isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/66086460911a4f87a48181ed1f80a081
work_keys_str_mv AT hidekitatsukawa isozymespecificcomprehensivecharacterizationoftransglutaminasecrosslinkedsubstratesinkidneyfibrosis
AT risaotsu isozymespecificcomprehensivecharacterizationoftransglutaminasecrosslinkedsubstratesinkidneyfibrosis
AT yujitani isozymespecificcomprehensivecharacterizationoftransglutaminasecrosslinkedsubstratesinkidneyfibrosis
AT ryosukewakita isozymespecificcomprehensivecharacterizationoftransglutaminasecrosslinkedsubstratesinkidneyfibrosis
AT kiyotakahitomi isozymespecificcomprehensivecharacterizationoftransglutaminasecrosslinkedsubstratesinkidneyfibrosis
_version_ 1718384660623392768